{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T17:04:39Z","timestamp":1761239079777,"version":"3.41.2"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T00:00:00Z","timestamp":1683676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>A patient complaining of edema of the face and lower extremities was admitted to the nephrology department for nephrotic syndrome. Renal biopsy revealed findings of minimal change disease (MCD). Thyroid ultrasound showed a hypoechoic 16 \u00d7 13 mm nodule in the right lobe, suspicious of malignancy. Later, total thyroidectomy confirmed the diagnosis of papillary thyroid carcinoma (PTC). After surgery, MCD remitted rapidly and completely, strongly suggesting the diagnosis of MCD secondary to PTC. We report here the first adult case of the paraneoplastic finding of MCD secondary to PTC. Additionally, we discuss the possible role of the <jats:italic>BRAF<\/jats:italic> gene in the pathophysiology of PTC-associated MCD in this case and highlight the importance of tumor screening.<\/jats:p>","DOI":"10.3389\/fmed.2023.1132259","type":"journal-article","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T12:14:55Z","timestamp":1683720895000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Minimal change disease associated with thyroid cancer: a case report"],"prefix":"10.3389","volume":"10","author":[{"given":"Xiaoyi","family":"Cai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuenv","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qijun","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"Glomerular Diseases Work Group. KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","author":"Kidney","year":"2021","journal-title":"Kidney Int."},{"key":"B2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1046\/j.1523-1755.1999.00548.x","article-title":"Paraneoplastic glomerulopathies: new insights into an old entity","volume":"56","author":"Ronco","year":"1999","journal-title":"Kidney Int."},{"key":"B3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.critrevonc.2008.08.003","article-title":"Paraneoplastic glomerular diseases and malignancies","volume":"70","author":"Bacchetta","year":"2009","journal-title":"Crit Rev Oncol Hematol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/antib9020018","article-title":"Glomerular diseases associated with malignancies: histopathological pattern and association with circulating autoantibodies","volume":"9","author":"Lionaki","year":"2020","journal-title":"Antibodies (Basel)."},{"key":"B5","doi-asserted-by":"publisher","first-page":"S154","DOI":"10.1016\/j.ekir.2020.02.389","article-title":"SAT-367 A case of thyroid papillary carcinoma associated with membranous anti-PLA2R positive glomerulonephritis. ISN World Congress of Nephrology (WCN) 2020 Abstracts","volume":"5","author":"Zirino","year":"2020","journal-title":"Kidney Int."},{"key":"B6","doi-asserted-by":"publisher","first-page":"368","DOI":"10.4103\/ijn.IJN_215_18","article-title":"Association of membranoproliferative glomerulonephritis with papillary carcinoma thyroid","volume":"29","author":"Pattanashetti","year":"2019","journal-title":"Indian J Nephrol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"714","DOI":"10.3760\/cma.j.issn.0578-1310.2019.09.014","article-title":"A case of minimal-change nephrotic syndrome complicated with thyroid carcinoma in children","volume":"57","author":"Liu","year":"2019","journal-title":"Zhonghua er ke za zhi."},{"key":"B8","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/978-3-319-29456-8","article-title":"The correct renal function evaluation in patients with thyroid dysfunction","volume":"39","author":"Simeoni","year":"2016","journal-title":"J Endocrinol Invest."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5301\/ijao.5000300","article-title":"The thyroid and the kidney: a complex interplay in health and disease","volume":"37","author":"Dousdampanis","year":"2014","journal-title":"Int J Artif Organs."},{"key":"B10","doi-asserted-by":"publisher","first-page":"951976","DOI":"10.3389\/fonc.2022.951976","article-title":"Thyroid and renal cancers: a bidirectional association","volume":"12","author":"Bellini","year":"2022","journal-title":"Front Oncol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nrendo.2011.142","article-title":"Molecular genetics and diagnosis of thyroid cancer","volume":"7","author":"Nikiforov","year":"2011","journal-title":"Nat Rev Endocrinol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e141380","DOI":"10.1172\/JCI141380","article-title":"Targeting a Braf\/Mapk pathway rescues podocyte lipid peroxidation in CoQ-deficiency kidney disease","volume":"131","author":"Sidhom","year":"2021","journal-title":"J Clin Invest."},{"key":"B13","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.chembiol.2017.11.006","article-title":"GDC-0879, a BRAF(V600E) inhibitor, protects kidney podocytes from death","volume":"25","author":"Sieber","year":"2018","journal-title":"Cell Chem Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1080\/21691401.2019.1601630","article-title":"Geniposide alleviates lipopolysaccharide-caused apoptosis of murine kidney podocytes by activating Ras\/Raf\/MEK\/ERK-mediated cell autophagy","volume":"47","author":"Li","year":"2019","journal-title":"Artif Cells Nanomed Biotechnol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1053\/j.ajkd.2016.12.013","article-title":"BRAF Signaling pathway inhibition, podocyte injury, and nephrotic syndrome","volume":"70","author":"Perico","year":"2017","journal-title":"Am J Kidney Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3389\/fmed.2018.00170","article-title":"Molecular and cellular mechanisms for proteinuria in minimal change disease","volume":"5","author":"Bertelli","year":"2018","journal-title":"Front Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.3389\/fimmu.2020.01124","article-title":"Interleukins in thyroid cancer: from basic researches to applications in clinical practice","volume":"11","author":"Xi","year":"2020","journal-title":"Front Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00262-014-1619-7","article-title":"Cytokine production in peripheral blood cells of patients with differentiated thyroid cancer: elevated Th2\/Th9 cytokine production before and reduced Th2 cytokine production after radioactive iodine therapy","volume":"64","author":"Simonovic","year":"2015","journal-title":"Cancer Immunol Immunother."},{"key":"B19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1210\/clinem\/dgaa656","article-title":"Inhibition of BRAF sensitizes thyroid carcinoma to immunotherapy by enhancing tsMHCII-mediated Immune Recognition","volume":"106","author":"Zhi","year":"2021","journal-title":"J Clin Endocrinol Metab."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1089\/thy.2014.0134","article-title":"V600E in papillary thyroid carcinoma is associated with increased programmed death ligand 1 expression and suppressive immune cell infiltration","volume":"24","author":"Angell","year":"2014","journal-title":"Thyroid."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1132259\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T12:15:12Z","timestamp":1683720912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1132259\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,10]]},"references-count":20,"alternative-id":["10.3389\/fmed.2023.1132259"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1132259","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2023,5,10]]},"article-number":"1132259"}}